Kaiser Permanente's ALL/PHASE Initiative Wins 2010 Care Continuum Alliance Quality Impact Award for Greatest Impact on Health
OAKLAND, Calif., Oct. 13 /PRNewswire/ -- The Care Continuum Alliance honored Kaiser Permanente's ALL/PHASE initiative with the Quality Impact Award for the "Greatest Impact on Health" at The Forum 10 conference today in Washington, D.C. The ALL/PHASE protocol, which utilizes low-cost and generic medications and clinical interventions to reduce heart attacks, has been successfully implemented in Kaiser Permanente communities, including those served by safety net organizations.
"Kaiser Permanente's ALL/PHASE protocol is an outstanding example of the emphasis on quality embodied by this award," said Tracey Moorhead, president and CEO, Care Continuum Alliance. "We're pleased to honor this important initiative to improve population health."
Kaiser Permanente's ALL initiative (Aspirin, Lisinopril and Lipid-lowering medication) was implemented to reduce heart attacks and strokes by aggressively enrolling patients with heart disease or patients who are at least 55 years old with diabetes, in a therapeutic program that included the use of these three medications. The organization's PHASE program (Preventing Heart Attacks and Strokes Everyday) enhances ALL by adding a beta blocker and emphasizing healthy lifestyle changes. Research has shown that bundling two low-cost, generic heart drugs – a cholesterol-lowering statin and a blood pressure-lowering drug – prevents heart attack and stroke.
Realizing the benefits for its members and community partners, Kaiser Permanente awarded Community Benefit grants to share this initiative with safety net clinics. Those grants led to the implementation of ALL in five community clinics in Southern California, and the use of PHASE in seven community clinics and four public hospital and health systems in Northern California.
"The ALL/PHASE initiative continues to be a proven keystone in Kaiser Permanente's cardio